Antitumor effect potentiator and antitumor agent

Details for Australian Patent Application No. 2004220205 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Shudo, Koyo; Uchida, Junji

Agent Griffith Hack

Pub. Number AU-B-2004220205

PCT Pub. Number WO2004/081012

Priority 2003-070097 14.03.03 JP

Filing date 11 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 17 June 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/081012 Priority application(s): WO2004/081012

17 June 2010 Application Accepted

  Published as AU-B-2004220205

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220209-Peptide fragment of LYVE-1 and antibody against the same

2004220187-Porous membrane of vinylidene fluoride resin and process for producing the same